Proximod

DRUG2 trials

Sponsors

Longevity Inc.

Conditions

Rheumatoid Arthritis

Phase 1

Proximod Pharmacokinetics in Healthy Subjects and Patients With Rheumatoid Arthritis

CompletedNCT06361199

Longevity Inc.Rheumatoid Arthritis

Start: 2021-12-16End: 2023-10-08Updated: 2024-04-19

Proximod Pharmacokinetics In Healthy Subjects

CompletedNCT06361186

Longevity Inc.Rheumatoid Arthritis

Start: 2017-09-14End: 2021-06-22Updated: 2024-04-11

Related Papers

Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial.

2024-10-221 citations